← Back to Search

Transition Coaching for Juvenile Arthritis (TRACER Trial)

N/A

Recruiting

Led By Michelle Batthish, MD

Research Sponsored by McMaster University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 year study period

Awards & highlights

TRACER Trial Summary

This trial will help find out if transition coaching sessions can help young people with rheumatology conditions move from paediatric to adult care.

Who is the study for?

This trial is for young people with pediatric-onset rheumatic diseases like arthritis and lupus, who are transitioning to adult care. Participants need a phone or device for video calls, must be available for the next 8 months, and able to communicate in English. Those with cognitive impairments that prevent participation in educational sessions cannot join.Check my eligibility

What is being tested?

The TRACER study is testing transition coaching sessions designed to help patients move from pediatric to adult rheumatology care smoothly. The feasibility of these coaching interventions through video conferencing will be evaluated.See study design

What are the potential side effects?

Since this trial involves non-medical intervention (coaching), there are no direct physical side effects associated with medications or procedures. However, participants may experience stress or anxiety related to the transition process.

TRACER Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 year study period

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 year study period

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 year study period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Consent rate

Enrolment from non-primary site

Missing data

+2 more

Secondary outcome measures

Active joint count

Global function/quality of life

Patient Reported Outcomes Measurement Information System (PROMIS) questionnaire

+1 more

TRACER Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Transition coaching - experimentalExperimental Treatment1 Intervention

Participants will receive 8 transition coaching sessions (1/month) in addition to standard care

Group II: Standard care - controlActive Control1 Intervention

Standard of care, appointments with adult rheumatology

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

McMaster UniversityLead Sponsor

884 Previous Clinical Trials

2,598,183 Total Patients Enrolled

Western UniversityOTHER

26 Previous Clinical Trials

128,408 Total Patients Enrolled

Michelle Batthish, MDPrincipal InvestigatorMcMaster University

Media Library

Transition coaching Clinical Trial Eligibility Overview. Trial Name: NCT05545839 — N/A

Autoimmune Diseases Research Study Groups: Standard care - control, Transition coaching - experimental

Autoimmune Diseases Clinical Trial 2023: Transition coaching Highlights & Side Effects. Trial Name: NCT05545839 — N/A

Transition coaching 2023 Treatment Timeline for Medical Study. Trial Name: NCT05545839 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the inclusion criteria for this experiment extending to those aged sixty and above?

"This clinical trial has a limited age-range, only permitting those between 17 and 18 to enroll. There are 78 trials tailored for minors while 391 studies cater to seniors above the age of 65."

Answered by AI

Are participants still being enrolled in this empirical research?

"As per the information provided on clinicaltrials.gov, this trial is still looking for suitable participants. It was first announced on October 17th 2022 and has had its data most recently updated March 16th 2023."

Answered by AI

Am I eligible to participate in this research trial?

"This clinical trial requires 133 participants aged 17-18 years, who have been diagnosed with an autoimmune condition. Furthermore, these volunteers must be: in the midst of transitioning from paediatric to adult rheumatology care; able to converse fluently in English; possess a device compatible with video calling technology and remain available for 8 months."

Answered by AI

What is the total number of participants in this clinical study?

"Affirmative. Clinicaltrials.gov data reveals that this medical study is currently recruiting patients, having been initially posted on October 17th 2022 and edited as recently as March 16th 2023. There are 133 eligible participants needed from two different sites."

Answered by AI

What are the major goals of this investigation?

"This 19-month clinical trial is primarily focussed on the rate of consent. Secondary objectives include an assessment of patient reported outcomes using PROMIS, global function/quality of life via PedsQL 4.0 Generic Core Scales Young Adult Version questionnaire, and active joint count which will be measured at baseline and subsequent follow-ups between the two groups."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Transition to Adulthood Through Coaching and Empowerment in Rheumatology

Michelle Batthish 2022. "Transition to Adulthood Through Coaching and Empowerment in Rheumatology". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05545839.

All > Juvenile Idiopathic Arthritis > Dermatomyositis